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Objective: This prospective study determined the incidence of signs and symptoms of chronic venous disease and recurrent
venous thrombotic events (VTE) in relation to the location and extent of the initial venous thrombus.
Methods: A first episode of acute deep vein thrombosis (DVT) occurred in 120 lower extremities of 105 patients (59 men;
mean age, 54 years [range, 23-82 years]). Patients who presented with pain, swelling, or signs and symptoms of
pulmonary embolism of <10 days were included. The DVT was diagnosed with duplex ultrasound (DUS) imaging.
Patients were grouped by those having thrombosis in one venous segment (group A) ormultiple levels (group B). Patients
were treated with heparin and warfarin. Patients with at least 1-year of follow-up with clinical and DUS were included.
Results: No difference was found in the duration of signs and symptoms at presentation. The median follow-up was 3.4
years (range, 1.2-7 years). More symptomatic limbs were seen in group B (71 of 79) compared with group A (21 of 41;
P< .001). Post-thrombotic syndrome (PTS) was more advanced in group B vs group A, including the prevalence of skin
damage and ulceration (61 of 79 vs 26 of 41, P< .001; 29 of 79 vs 6 of 41, P .019, respectively). Limbs with calf DVT
that had focal thrombosis were most often asymptomatic. Calf thrombosis in patients with proximal DVT produced the
highest prevalence of PTS. Venous claudication was exclusively found in group B and was present only when iliac veins
were involved. Recurrent thrombosis had a trend for a higher prevalence in group B (5 of 41 vs 16 of 79, P .39). Reflux,
obstruction, or a combination of the two were more common in group B (61 of 79) vs group A (15 of 41; P < .0001).
Limbs with both reflux and obstruction were more likely to develop skin damage (group A, 5 of 6 vs 1 of 35, P < .0001;
group B, 24 of 29 vs 5 of 50, P < .0001).
Conclusions:Recurrent thrombosis and skin damage is more likely to develop in patients with multiple sites of thrombosis
than in those with thrombosis in a single vein segment. Patients with reflux and obstruction presented more skin damage
than those with reflux or obstruction alone. Involvement of the calf veins in the presence of proximal vein thrombosis
increased the likelihood for PTS. (J Vasc Surg 2008;48:407-12.)Acute venous thrombosis is a common problem and
often leads to thrombus propagation, pulmonary embolism
(PE), recurrent events, and post-thrombotic syndrome
(PTS). The latter is frequent, occurring in 30% to 60% of
patients that have venous thromboembolism (VTE).1,2
This chronic condition includes telangiectasia, varicose
veins, pigmentation, heaviness, swelling, venous claudica-
tion, and ulceration rarely leading to amputation.3 The
social and economic burden of PTS is considerable, with
significant impact on quality of life.4
There remain conflicting results regarding the mecha-
nism of PTS and whether proximal or distal deep vein
thrombosis (DVT) is more likely to be associated with
symptoms. Several studies have compared the extent and
location of acute DVT with the presence and severity of
PTS. However, these findings are given segmentally in
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doi:10.1016/j.jvs.2008.03.016different reports and some results are conflicting, making it
difficult to extract solid conclusions. This prospective study
was designed to determine the incidence of signs and
symptoms of chronic venous disease (CVD) and recurrent
VTE in relation to both the location and extent of the initial
venous thrombus.
PATIENTS AND METHODS
Patients with a first episode of acute DVT in the lower
extremity were included. These patients presented with
pain, swelling, or signs and symptoms of PE of 10 days.
Diagnosis of DVT was by duplex ultrasound (DUS) imag-
ing. In some patients with inferior vena cava (IVC) and iliac
thrombosis, diagnosis was by venography, either by com-
puted tomography (CT) or magnetic resonance imaging,
or phlebography, but these were confirmed by DUS. Pa-
tients were separated into two groups. Group A patients
had isolated thrombosis in one venous segment (ie, in the
popliteal vein only). Group B patients had at least two
different levels involved (ie, the popliteal and femoral
veins). Both groups were treated with heparin and warfarin.
Excluded from the study were patients with previous
DVT, thrombolysis, signs and symptoms of CVD before
thrombosis, a short life expectancy (2 years), immobility
(unable to walk), major bleeding requiring interruption of
anticoagulation, and those with an ankle-brachial index
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examination and DUS. All patients had to have at least 1
year of follow-up by clinical examination and DUS.
The signs and symptoms of CVD were recorded using
the CEAP system.5 Causes for thrombosis were recorded in
detail. This included most of the well-known factors for
VTE, such as trauma, surgery, catheterization, thrombo-
philia, family history, malignancy, and prolonged travel.
Family history was positive when at least one first-degree
relative had an episode of VTE during traveling when it was
uninterrupted for 4 hours.
Symptoms of itching, burning sensation, pain, heavi-
ness, and venous claudication were recorded. Venous clau-
dication was considered to be present when patients were
unable to walk more than a block without a pain despite
having an ABI of0.8. These patients had swelling and the
limb was feeling tighter after walking.
Distribution and extent of reflux, obstruction, and
recurrent DVT was assessed by DUS. Patients with signs
and symptoms of PE underwent spiral CT. Recanalization
was considered complete when no intraluminal material
was detected, nearly complete when wall thickening or a
few intraluminal webs were seen, partially complete when
intraluminal material was detected, and absent when the
whole lumen was occluded. Limbs were separated into
normal, those having reflux, obstruction, and those with
combined reflux and obstruction.
DUS was performed with multifrequency linear array
transducers. Curvilinear array of 2- to 3-MHz was used in
obese patients and for the iliocaval veins. Detection of DVT
was performed in the supine position. IVC and iliac vein
obstruction was tested in the supine and in the lateral
decubitus position with the arm placed behind the head
ipsilateral to the side of imaging. The infrainguinal veins
were examined in the supine position. When the imaging
was not adequate, such as the inability clearly delineate a
duplicated femoral or popliteal vein, it was performed in the
sitting or standing position. The reflux test was performed
in the standing position. If the patient was unable to stand
for long, the groin area was examined in the standing
position and the rest of the examination was in the sitting
position.
The cutoff value for reflux was set at 1 second in the
common femoral, femoral, and popliteal veins; at 0.5 sec-
onds in the deep femoral, deep calf veins, and superficial
veins; and at 0.35 seconds in the perforator veins.6 Manual
compression was used in all areas in all venous segments. If
this maneuver had a negative result in the proximal femoral
and deep femoral veins and higher, the Valsalva maneuver
was used as well. In limbs with significant edema, dorsi/
plantar flexion was used when the result of manual com-
pression was negative.
The criteria used for the diagnosis of acute and chronic
thrombosis have been published elsewhere in detail.7 The
diagnosis of recurrent thrombosis was made by using the
following criteria: extension of thrombus of 9 cm, non-
compressibility of a vein segment that has been previouslyrecanalized, and enlargement of the thrombus thickness by
2 mm.8-10
After the initial DUS at diagnosis, two clinical exami-
nations and a repeat DUS were performed in the first 6
months, and a clinical examination and DUS were repeated
at 1 year and then yearly thereafter. Because these patients
had known thrombosis, DUS was done for both obstruc-
tion and reflux. Clinical examination and DUS were also
done whenever the patients had new signs and symptoms
of VTE.
Statistical analysis. Descriptive statistics were used to
analyze patient characteristics. A two-tailed t test was used
to analyze continuous data, and comparison of proportions
was performed with a 2 test. The Fisher’s exact test was
used when the expected value in any of the cells was 5.
Statistical significance was set at P  .05.
RESULTS
From an original 192 consecutive patients, the study
included 120 limbs of 105 patients (59 men and 46
women) who were a mean age of 54 years (range, 23-82
years). Groups A and B were comparable in age and sex.
Excluded were 45 patients owing to previous DVT (n 8),
CVDbefore DVT (n 11), early fatal PE (n 2), short life
expectancy (n  6), immobility (n  3), major bleeding
(n 3), and thrombolysis treatment (n 12). The remain-
ing 42 patients were excluded because they did not com-
plete at least 1 year of follow-up, either because they chose
not to come (n  36) or because they moved to another
area (n  6). The causes for thrombosis are reported in
Table I. Thrombophilia alone or combined with cancer had a
trend for a higher prevalence in group B (20 of 79) compared
with group A (6 of 41; P .2). At presentation, group A and
group B had similar duration of signs (range, 1-9 days vs 1-7
day) and symptoms (range, 2-8 days vs 1-6 days). Themedian
follow-up was 3.4 years (range, 1.2-7 years).
The distribution and extent of thrombosis as well as the
prevalence of signs and symptoms are reported in Tables II
and III. The extent of thrombosis was longer in group B
because these patients had multisegmental thrombosis and
also had more symptomatic limbs (21 of 41 vs 71 of 79,
P  .001). This was true for all symptoms, whether exam-
Table I. Causes of thrombosis
Cause Group A, No. Group B, No.
Family historya 3 6
Trauma 6 8
Surgery 8 11
Thrombophilia 4 17
Travel 4 hours 2 5
Extrinsic compression 2 4
Catheter 4 5
Tumor 2 3
Unknown 7 8
Total 38 67
aFamily history was present in 5 additional patients in group A and in 7 in
group B that had also one of the other factors present.ined together or separately.
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the distribution of thrombosis is summarized in Tables IV
and V. More advanced PTS was found in group B (61 of
79) vs group A (26 of 41; P  .001), including the
prevalence of skin damage and ulceration (29 of 79 vs 6 of
41, P  .019). Limbs with calf DVT that had focal throm-
bosis or only one vein involved remained in CEAP class 0
and were most often asymptomatic, and those with throm-
bosis in multiple calf veins developed symptoms and were
Table II. Location of thrombi and signs and symptoms
in patients with isolated vein thrombosis
Segment
Patients,
No.
Limbs, No.
Signs Symptoms
Inferior vena cava 3 4a 2
Common iliac vein 2 2 1
External Iliac vein 2 2 1
Common femoral vein 6 6 4
Femoral vein 3 1 1
Popliteal vein 7 6 5
Calf veins 15 7 7
Total 38 28 21
The total number of patients was 38 and the limbs 41.
aPatients with inferior vena cava thrombosis could have bilateral signs and
symptoms.
Table III. Distribution and extent of thrombosis, signs,
and symptoms in patients with multisegmental deep
venous thrombosis
Segments
Patients,
No.
Limbs, No.
No. Signs Symptoms
IF  IVC 7 9 8 8
IF  fem-pop 9 10 8 9
IF  fem-pop  calf 11 13 13 13
Fem-pop 16 19 14 18
Fem-pop  calf 24 28 26 23
Total 67 79 69 71
Fem-pop, Femoral-popliteal; IF, iliofemoral; Pop, popliteal.
Table IV. CEAP classification in patients with isolated
vein thrombosis
Segment
Limbs, No.
Total
Class
0-1
Class
2-3
Class
4a
Class
5-6
Inferior vena cava 6 2 3 1 0
Common iliac vein 2 0 2 0 0
External iliac vein 2 1 1 0 0
Common femoral vein 6 1 4 1 0
Femoral vein 3 2 1 0 0
Popliteal vein 7 1 4 2 0
Calf veins 15 8 5 2 0
Total 41 15 20 6 0
aFour limbs were in CEAP class 4A and 2 were in class 4B.most often in CEAP class 3 and, occasionally, in class 4.Venous claudication was exclusively found in group B (7 of
79) and was present only when iliac veins were involved.
Calf thrombosis in one vein segment resolved faster and
produced no signs and symptoms of CVD. Patients with
multiple calf vein involvement presented with swelling and,
in two occasions, skin changes. The presence of calf vein
thrombosis in patients with proximal DVT increased the
likelihood they would present with post-thrombotic signs
and symptoms (proximal veins, 30 of 38 vs proximal and
calf veins, 39 of 41; P .04). Only two of 28 patients with
calf vein involvement in group B were in class 0 but were
symptomatic, with itching and burning sensation in one
and pain in the other; whereas in eight of 38 limbs with
proximal DVT alone in class 0, four patients were symp-
tomatic (P  .17).
Recurrent thrombosis had a trend for a higher preva-
lence (P .39) in group B (16 of 79) compared with group
A (5 of 41). The total number of recurrent thrombotic
events was 20, because two patients had two recurrent
episodes and another patient had three recurrent episodes.
Clinical symptoms of PE were found in four patients (9.7%)
in group A and in 16 (20.3%) of group B (P .2). On spiral
CT, PE was present in one of four in group A and in six of
16 in group B (P .6 and P .2 among all patients in both
groups). Because of the study design, two additional pa-
tients with early fatal PE in group B were excluded from
analysis. One fatal PE occurred at 42 months in group B.
Venous pathology was more common in group B (61
of 79) compared with group A (15 of 41; P  .0001). In
group B, reflux was found in 23 limbs, obstruction in 6, and
a combination of reflux and obstruction in 32; whereas in
group A, reflux was found in 6, obstruction in 2, and a
combination of reflux and obstruction in 6. Five of the six
limbs with skin damage (CEAP classes 4 to 6) in group A
had reflux and obstruction, and 24 of the 29 limbs with skin
damage in group B had reflux and obstruction; therefore,
limbs with both reflux and obstruction were more likely to
develop skin damage in either group (group A, 5 of 6 vs 1
of 35, P .0001; group B, 24 of 29 vs 5 of 50, P .0001).
All eight limbs in which an ulcer developed had a
multisegmental thrombosis (group B), of which four had a
Table V. CEAP classification in patients with vein
thrombosis in multiple segments
Segment
Limbs, No.
Total
Class
0-1
Class
2-3
Class
4a
Class
5-6
IF  IVC 9 1 4 3 1
IF  fem-pop 10 2 4 3 1
IF  fem-pop  calf 13 0 6 5 2
Fem-pop 19 5 8 4 2
Fem-pop  calf 28 2 18 6 2
Total 79 10 40 21 8
Fem-pop, femoral-popliteal; IF, iliofemoral; Pop, popliteal.
aThirteen limbs were in CEAP class 4A and 8 were in class 4B.recurrent DVT and one was in a patient who was obese. All
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developed at 2 years, one at 3 years, and six at3 years. Of
the limbs that developed skin changes (6 in group A and 21
in group B), 2 appeared in the first year, 3 in the second
year, 9 at 3 years, and 13 at 3 years.
DISCUSSION
The current study has a well-defined patient population
in which the location and extent of thrombosis at baseline
were established, coupled with a rigorous follow-up in
which signs, symptoms, and severity of PTS, venous clau-
dication, recurrent VTE, and clinically relevant PE were
documented. The use of the CEAP classification system in
a prospective fashion has allowed the study of the natural
history of VTE in a consistent manner with a more valid
comparison among the different groups.
The patients were selected to have a reasonable life
expectancy such that enough time would elapse to docu-
ment the frequency and severity of PTS. Patients with
impaired mobility were excluded because this by itself
would have been a significant risk factor for developing
CVD. Patients with previous thrombosis, CVD, and an
ABI 0.8 were also excluded to permit the study of the
DVT impact on an unaffected extremity. The signs and
symptoms of VTE were present for 10 days, allowing a
uniform time effect of thrombosis in the involved extrem-
ity. Recurrent VTE was well documented and reported in
relation to previous distribution of DVT.
Patients with symptomatic DVT are at an increased risk
for recurrence.11 It has been shown that PTS occurs in
approximately 30% to 60% of patients 5 to 10 years after the
initial DVT1,2,12 and is approximately six times more likely
to occur in patients with ipsilateral recurrent DVT.1 In
addition, Johnson et al12 showed that abnormal findings in
PTS patients are more common in the deep venous seg-
ments of the lower extremities compared with extremities
without PTS.12 In the current study, skin damage devel-
oped in 35 limbs (29%) at a mean follow-up of 3.4 years.
The prevalence of skin damage was more common in group
B, and the time taken for its development was 3 years in
most limbs. Mild skin changes (CEAP class 4A) were noted
in 15 limbs.
Effects of distribution and extent of thrombosis on
PTS development in the IVC and iliac veins. With the
exception of the calf veins, isolated thrombosis is uncom-
mon.13 In isolated thrombi, multiple pathways bypass the
obstruction; therefore, the prevalence and severity of signs
and symptoms in such patients was reduced compared with
those with multisegmental thrombosis, even when the iso-
lated thrombus was located in the IVC. Raju et al13 found
10% of IVC obstructions had no, transient, or mild occlu-
sive symptoms.13 In a well-developed collateral system,
IVC aplasia or hypoplasia is asymptomatic, whereas it is
symptomatic if a well-developed system is not present.13,14
Several collateral pathways bypass IVC obstruction, such as
the azygous system, thoracolumbar, and thoracoepigastric
veins. The azygous system may become so dilated that it
appears as a left-sided IVC or duplicate venae cavae.13,14Two-thirds of patients with iliocaval thrombosis had
signs and symptoms ipsilateral to the iliac vein involved.13
Given that the collateral network in IVC occlusion receives
drainage from the iliac veins, it is crucial that the iliac veins
remain patent. Patients with isolated iliac thrombosis in our
study had mild signs and symptoms, but when the iliac vein
was occluded in conjunction with other veins, the fre-
quency and severity of PTS increased; for example, venous
claudication occurred only in patients with multisegmental
DVT where the iliac veins were involved.
Infrainguinal veins. Patients with isolated thrombo-
sis below the iliac veins presented with mild signs and
symptoms or were asymptomatic. Multiple collateral path-
ways are present at these levels.15 The femoral vein is
duplicated in 25% to 30% and the popliteal vein in 35% to
40% of the population, and triplications are seen in 3%.16 In
patients with isolated calf DVT, 60% were in CEAP class 0.
These patients had focal thrombosis, and when multiple
calf veins were thrombosed, the severity of PTS was worse.
Incompetence of the popliteal valves was more predic-
tive of ulceration than recanalization or extent of DVT.17
Poor popliteal vein function has been correlated with a
worse clinical picture in the affected limb.18 Johnson et al19
found patients with popliteal vein abnormalities to be3.5
times more likely to develop PTS. A high peak reflux
velocity in the popliteal vein was a strong predictor for
CVD,20 whereas Meissner et al21 showed the popliteal vein
involvement to be among the major determinants of CVD.
Accordingly, patients with multisegmental occlusion in-
volving the popliteal vein are at a further risk for developing
PTS.
It has been shown that in the presence of an occluded
femoral vein, collateral pathways were rapidly established,
with no evidence of collateral reflux.22 Regardless of the
nature of the collateral system involved, the extension of
thrombosis seems to determine the severity of PTS. In our
opinion this will more often occur in the presence of reflux
or combined reflux and obstruction. It is unlikely to occur
in patients with obstruction alone because it can be by-
passed by the collateral veins, particularly in patients with
duplicated veins.
In the current study, multisegmental DVT generated a
measurable yet nonstatistically significant increase in inci-
dence of venous claudication, recurrent DVT, and symp-
toms of PE compared with isolated DVT. A significantly
increased prevalence of skin changes (CEAP C4 classifica-
tion) was noted compared with isolatedDVT. These results
are a function of the relatively small sample size.
Calf DVT. The current study found that thrombosis
in multiple calf veins produced more frequent and more
significant PTS than thrombosis in a single calf vein. To our
knowledge, such an analysis has not been published, and
this may partially explain the controversy on the develop-
ment of PTS after calf DVT.23 Recurrent ipsilateral epi-
sodes in patients with calf DVT have not been taken into
account in previous studies. Calf vein involvement in the
presence of proximal DVT was also found to increase the
likelihood of PTS.24 Yamaki et al25 showed improved rates
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thrombi compared with proximal vein thrombi, and this
could explain why proximal DVT may be more significant
in the development of PTS.26,27 Calf thrombi may recana-
lize faster due to the effect of the calf muscle pump.2 In
addition, the thrombus load is related to the rate of recan-
alization.28 The calf veins have less thrombus load than the
proximal and therefore may recanalize faster.29,30
Recurrent DVT. Patients in group B had more often
recurrent DVT and also a greater severity of symptoms.
Ipsilateral recurrent DVT has an increased risk for develop-
ing PTS (hazard ratio, 6.4).1 Ziegler et al24 demonstrated
that of the 30% of patients with recurrent DVT, recurrence
was ipsilateral in 16%. Those with ipsilateral recurrent DVT
developed PTS more often and also experienced more
severe signs and symptoms.24 They also showed that ipsi-
lateral recurrence was a more important prognostic fac-
tor for developing PTS than was the initial extent of
thrombosis.24
The segments initially involved are also important in
the development of PTS. It has been shown that venous
abnormalities present in the popliteal and tibial veins have a
greater likelihood than proximal veins of leading to PTS.12
The extent of segment involvement determines the severity
of PTS. Initial multisegmental thrombi lead to a higher
percentage of PTS development than single-segment
thrombi.12,19,24
Effects of reflux and residual obstruction. Patients
with residual thrombi are at an increased risk for obstruc-
tion and reflux secondary to recurrence or new thrombo-
sis.31,32 Recurrent thrombosis is more likely to occur in
patients with previous iliofemoral thrombosis.33 The pres-
ence of either reflux or obstruction has been shown to
increase the risk for developing PTS. Limbs with PTS were
3.5 times more likely to have reflux and obstruction than
limbs without.19 Although obstruction in the absence of
reflux is rare, the coexistence of reflux and obstruction is a
common finding.19 The current study found the combi-
nation of reflux and obstruction was more predictive of
subsequent PTS than the presence of either condition
alone, in accordance with the findings of multiple arti-
cles. This result corroborates the relationship suggested
by Singh and Masuda.34
Limitations. Limitations of the study include pres-
ence of other factors that influence the development of
CVD, such as obesity, age, and joint problems. Although a
clinical examination was always performed, not all the
patients had a repeat DUS study every year after the com-
pletion of the first year. The lack of physiologic testing did
not permit us to study the effect of reflux, obstruction, and
the calf muscle pump function. Asymptomatic patients with
similar DVT distribution and extent were not tested to see
if their natural history was comparable.
The small sample size in relation to various venous
segments did not allow subdividing patients to analyze the
anatomic variations in femoral and popliteal veins or to
make statements for a single level in the proximal veins.This was also evident in cases with a low yield of symptoms,
such as in patients with venous claudication.
The median follow-up was 3.4 years, but ideally, all
patients should have completed a 5-year follow-up.
Not all the patients received the same treatment, be-
cause the use of unfractionated heparin and low-molecular-
weight heparin was at the discretion of the treating physi-
cians. The duration of the anticoagulation was not equal
even if sometimes the location of thrombosis and the
history of the patients were similar. All patients were asked
to wear stockings for at least 2 years, but we did not
monitor their use.
Some patients developed reflux in the superficial veins
that were previously thrombosed, whereas others devel-
oped superficial vein reflux in the absence of thrombosis.
The information on the extent of superficial vein thrombo-
sis was not recorded in detail in more than a quarter of the
patients and therefore the effect of the reflux in these veins
was not accounted.
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